- Home
- TCX vs CRVO Comparison
TCX vs CRVO Comparison
Compare TCX & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- CRVO
- Stock Information
- Founded
- TCX 1992
- CRVO 2001
- Country
- TCX Canada
- CRVO United States
- Employees
- TCX N/A
- CRVO N/A
- Industry
- TCX EDP Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- TCX Technology
- CRVO Health Care
- Exchange
- TCX Nasdaq
- CRVO Nasdaq
- Market Cap
- TCX 179.0M
- CRVO 160.4M
- IPO Year
- TCX 1996
- CRVO N/A
- Fundamental
- Price
- TCX $16.27
- CRVO $9.58
- Analyst Decision
- TCX
- CRVO Strong Buy
- Analyst Count
- TCX 0
- CRVO 6
- Target Price
- TCX N/A
- CRVO $53.67
- AVG Volume (30 Days)
- TCX 50.4K
- CRVO 78.8K
- Earning Date
- TCX 11-07-2024
- CRVO 11-12-2024
- Dividend Yield
- TCX N/A
- CRVO N/A
- EPS Growth
- TCX N/A
- CRVO N/A
- EPS
- TCX N/A
- CRVO N/A
- Revenue
- TCX $356,135,000.00
- CRVO $10,066,550.00
- Revenue This Year
- TCX $8.16
- CRVO $54.67
- Revenue Next Year
- TCX N/A
- CRVO N/A
- P/E Ratio
- TCX N/A
- CRVO N/A
- Revenue Growth
- TCX 7.50
- CRVO 116.29
- 52 Week Low
- TCX $15.01
- CRVO $5.85
- 52 Week High
- TCX $28.66
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- TCX 37.25
- CRVO 27.48
- Support Level
- TCX $15.57
- CRVO $9.31
- Resistance Level
- TCX $16.24
- CRVO $11.44
- Average True Range (ATR)
- TCX 0.89
- CRVO 0.90
- MACD
- TCX -0.02
- CRVO -0.23
- Stochastic Oscillator
- TCX 31.74
- CRVO 6.34
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.